- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New Guidance for Percutaneous Lung Ablation
Position statement supports radiofrequency ablation, cryoablation, and microwave ablation as appropriate image-guided treatment options.
There’s new guidance available for percutaneous lung ablation from the Society of Interventional Radiology (SIR).
In an article published Aug. 1 in the Journal of Vascular and Interventional Radiology, experts shared recommendations for patient selection, treatment, and follow-up, as well as a patient safety quality-improvement guide.
Image-directed percutaneous ablation is widely used to treat various types of lung cancer in minimally invasive ways.
“Minimally invasive, image-guided thermal ablation offers patients with early stage, non-small-cell lung cancer, recurring lung cancer, and metastatic disease a safe and effective treatment option,” said statement author Mark Baerlocher, M.D., SIR’s standards division councilor and interventional radiologist at Royal Victoria Hospital in Ontario. “The two publications provide physicians with guidance [to]...[ensure] high-quality care that improves patients’ lives.”
Creation of the position statement was supported by the Canadian Association for Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, and the Society of Interventional Radiology. The statement itself was drafted by a team of interventional radiologists, oncologists, thoracic surgeons, and radiation oncologists.
Based on a literature review of 63 studies, the new recommendations are grounded in current evidence that points to the appropriateness of radiofrequency ablation, cryoablation, and microwave ablation as image-guided tools that can be used to treat primary and secondary lung cancer. They noted that lesion characteristics and risk mitigation should be used to choose which ablation method to use.
According to SIR President Mathew S. Johnson, M.D., FSIR, Gary J. Becker Professor of Radiology Research at Indiana University School of Medicine, publishing this evidence-based position statement is critical to improving patient outcomes. But, additional comparative studies on thermal ablation use in treating lung cancer will further strengthen guidance in the future.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
